Does TAFASITAMAB Cause General physical health deterioration? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of General physical health deterioration have been filed in association with TAFASITAMAB (MONJUVI). This represents 5.4% of all adverse event reports for TAFASITAMAB.
75
Reports of General physical health deterioration with TAFASITAMAB
5.4%
of all TAFASITAMAB reports
33
Deaths
33
Hospitalizations
How Dangerous Is General physical health deterioration From TAFASITAMAB?
Of the 75 reports, 33 (44.0%) resulted in death, 33 (44.0%) required hospitalization, and 20 (26.7%) were considered life-threatening.
Is General physical health deterioration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
Thrombocytopenia (60)
What Other Drugs Cause General physical health deterioration?
METHOTREXATE (5,767)
ADALIMUMAB (5,718)
INFLIXIMAB (5,403)
RITUXIMAB (5,178)
ABATACEPT (4,832)
LEFLUNOMIDE (4,420)
PREDNISONE (4,402)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (4,332)
TOCILIZUMAB (4,254)
ETANERCEPT (3,898)
Which TAFASITAMAB Alternatives Have Lower General physical health deterioration Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR